# Amylyx Pharmaceuticals, Inc.: Form S-1, filed Oct 4, 2022

- Company: [Amylyx Pharmaceuticals, Inc.](/companies/amlx.md) (CIK 1658551)
- Form: S-1
- Filed: 2022-10-04
- Accepted by EDGAR: Oct 4, 2022, 16:03 ET
- Period: not reported
- Accession: 0001193125-22-257577
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1658551/000119312522257577/d383770ds1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1658551/000119312522257577/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1658551/000119312522257577/d383770ds1.htm

Filed Oct 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-257577. Last ingested by Listed: Nov 13, 2026, 14:43 ET. No prices; not investment advice.
